412 related articles for article (PubMed ID: 19023828)
41. A Survey of N'-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015.
Ammann JR; Lovejoy KS; Walters MJ; Holman MR
J Agric Food Chem; 2016 Jun; 64(21):4400-6. PubMed ID: 27192054
[TBL] [Abstract][Full Text] [Related]
42. Chemical composition and carcinogenicity of smokeless tobacco.
Hoffmann D; Djordjevic MV
Adv Dent Res; 1997 Sep; 11(3):322-9. PubMed ID: 9524432
[TBL] [Abstract][Full Text] [Related]
43. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties.
Ding YS; Zhang L; Jain RB; Jain N; Wang RY; Ashley DL; Watson CH
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3366-71. PubMed ID: 19064552
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
45. Tobacco alkaloids and tobacco-specific nitrosamines in dust from homes of smokeless tobacco users, active smokers, and nontobacco users.
Whitehead TP; Havel C; Metayer C; Benowitz NL; Jacob P
Chem Res Toxicol; 2015 May; 28(5):1007-14. PubMed ID: 25794360
[TBL] [Abstract][Full Text] [Related]
46. Receptivity to Taboka and Camel Snus in a U.S. test market.
Biener L; Bogen K
Nicotine Tob Res; 2009 Oct; 11(10):1154-9. PubMed ID: 19564175
[TBL] [Abstract][Full Text] [Related]
47. Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products.
Stepanov I; Yershova K; Carmella S; Upadhyaya P; Hecht SS
Nicotine Tob Res; 2013 Jul; 15(7):1305-10. PubMed ID: 23212437
[TBL] [Abstract][Full Text] [Related]
48. Variations of toxic and carcinogenic constituents in nasvai: call for systematic research and regulation.
Stepanov I; Abrams J; Jain V; Walter K; Kittner DL
Tob Control; 2017 May; 26(3):355-356. PubMed ID: 27255119
[No Abstract] [Full Text] [Related]
49. Comparison of tobacco-specific nitrosamine levels in smokeless tobacco products: High levels in products from Bangladesh.
Nasrin S; Chen G; Watson CJW; Lazarus P
PLoS One; 2020; 15(5):e0233111. PubMed ID: 32453764
[TBL] [Abstract][Full Text] [Related]
50. Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry.
Stepanov I; Knezevich A; Zhang L; Watson CH; Hatsukami DK; Hecht SS
Tob Control; 2012 Jan; 21(1):44-8. PubMed ID: 21602537
[TBL] [Abstract][Full Text] [Related]
51. Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK.
Schick SF; Farraro KF; Perrino C; Sleiman M; van de Vossenberg G; Trinh MP; Hammond SK; Jenkins BM; Balmes J
Tob Control; 2014 Mar; 23(2):152-9. PubMed ID: 23716171
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.
Seidenberg AB; Ayo-Yusuf OA; Rees VW
Nicotine Tob Res; 2018 Jan; 20(2):262-266. PubMed ID: 28003512
[TBL] [Abstract][Full Text] [Related]
53. Smokeless tobacco and oral cancer: a review of the risks and determinants.
Rodu B; Jansson C
Crit Rev Oral Biol Med; 2004 Sep; 15(5):252-63. PubMed ID: 15470264
[TBL] [Abstract][Full Text] [Related]
54. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
Rahman Z; Dharani S; Khuroo T; Khan MA
AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity of Harmful Constituent Profiles in Smokeless Tobacco Products from Five African Countries.
Gomez F; Ayo-Yusuf O; Yershova K; Jain V; Alcheva A; Hatsukami DK; Parascandola M; Stepanov I
Chem Res Toxicol; 2023 Dec; 36(12):1901-1911. PubMed ID: 38051542
[TBL] [Abstract][Full Text] [Related]
56. Examining Market Trends in Smokeless Tobacco Sales in the United States: 2011-2019.
Delnevo CD; Hrywna M; Miller Lo EJ; Wackowski OA
Nicotine Tob Res; 2021 Aug; 23(8):1420-1424. PubMed ID: 33241271
[TBL] [Abstract][Full Text] [Related]
57. Carcinogenic agents in snuff.
Hoffmann D; Harley NH; Fisenne I; Adams JD; Brunnemann KD
J Natl Cancer Inst; 1986 Mar; 76(3):435-7. PubMed ID: 3456461
[TBL] [Abstract][Full Text] [Related]
58. Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products.
Hecht SS; Stepanov I; Hatsukami DK
Tob Control; 2011 Nov; 20(6):443. PubMed ID: 20930058
[No Abstract] [Full Text] [Related]
59. Smokeless tobacco products harbor diverse bacterial microbiota that differ across products and brands.
Smyth EM; Kulkarni P; Claye E; Stanfill S; Tyx R; Maddox C; Mongodin EF; Sapkota AR
Appl Microbiol Biotechnol; 2017 Jul; 101(13):5391-5403. PubMed ID: 28432442
[TBL] [Abstract][Full Text] [Related]
60. Associations between microbial communities and key chemical constituents in U.S. domestic moist snuff.
Tyx RE; Rivera AJ; Satten GA; Keong LM; Kuklenyik P; Lee GE; Lawler TS; Kimbrell JB; Stanfill SB; Valentin-Blasini L; Watson CH
PLoS One; 2022; 17(5):e0267104. PubMed ID: 35507593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
